Eli Lilly launches diabetes-obesity management drug Mounjaro in India
The drug, typically taken once a week, would cost between Rs 14,000 and Rs 17,500 per month, depending on the dosage ...
Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India. Price here
Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India-here's what ...
Dear Doctor: Is it true that people with alcohol addiction can get help by taking GLP-1 drugs?
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
Your Good Health: A GLP-1 agonist can help reduce weight, sleep apnea and more
He also has untreated sleep apnea. He would like to try one of the GLP-1 drugs to lose some weight, but I am concerned about ...
I lost 8st on Mounjaro in 9 months – yes I have loose skin but it’s worth it, I was eating 4,000 calories a day before
A WOMAN has left ht internet stunned after losing 8 stone in just 9 months with Mounjaro. Jess, from the UK, says she is so ...
Expert sheds light on medical breakthroughs in obesity treatment
Unlock the latest advancements in obesity treatment. Expert insights reveal groundbreaking medical breakthroughs and ...
ETX Daily Up on MSN20h
Is BMI a misleading tool for measuring obesity?
Is BMI a misleading tool for measuring obesity? However, longitudinal studies will be necessary to confirm these observations and refine the tools for measuring obesity across the ages.
24/7 Wall St.20h
Novo Nordisk (NVO) Price Prediction and Forecast 2025-2030 (March 2025)
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...